Pyrviniumpamoate (PP) is a potent noncompetitive inhibitor of the AR in PCa which inhibits activity of the AR-Vs via binding at the interface of the DBD dimer and the minor groove of the ARE [121]. This evidence concerns the gene AR and posterior cortical atrophy.